Switching antidepressants after a first selective serotonin reuptake inhibitor in major depressive disorder: a systematic review.

@article{Ruh2006SwitchingAA,
  title={Switching antidepressants after a first selective serotonin reuptake inhibitor in major depressive disorder: a systematic review.},
  author={H. Ruh{\'e} and J. Huyser and J. Swinkels and A. Schene},
  journal={The Journal of clinical psychiatry},
  year={2006},
  volume={67 12},
  pages={
          1836-55
        }
}
  • H. Ruhé, J. Huyser, +1 author A. Schene
  • Published 2006
  • Psychology, Medicine
  • The Journal of clinical psychiatry
    • OBJECTIVE Selective serotonin reuptake inhibitors (SSRIs) are frequently used as a first antidepressant for major depressive disorder but have response rates of 50% to 60% in daily practice. For patients with insufficient response to SSRIs, switching is often applied. This article aims to systematically review the evidence for switching pharmacotherapy after a first SSRI. DATA SOURCES A systematic literature search (updated until Feb. 10, 2005) in MEDLINE, EMBASE, CINAHL, and PsychINFO (all… CONTINUE READING
    View PDF
    202 Citations
    Highly Influencial Citations
    10
    Background Citations
    59
    Methods Citations
    8
    Results Citations
    16
    202 Citations
    Citation Type

    Citation Type

    Sertraline treatment of patients with major depressive disorder who failed initial treatment with paroxetine or fluvoxamine
    • 4
    Pharmacologic approaches to treatment resistant depression: Evidences and personal experience.
    • 42
    • PDF
    Citalopram versus desipramine in treatment resistant depression: Effect of continuation or switching strategies. A randomized open study
    • D. Souery, A. Serretti, +8 authors J. Mendlewicz
    • Medicine
    • The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry
    • 2011
    • 41
    Pharmacy and medical costs associated with switching between venlafaxine and SSRI antidepressant therapy for the treatment of major depressive disorder.
    • 26
    • PDF
    Early Switching Strategies in Antidepressant Non-Responders: Current Evidence and Future Research Directions
    • 37
    • PDF
    Switching to duloxetine from selective serotonin reuptake inhibitors in non- or partial responders: Results from a Spanish sample
    • 3
    Pharmacological interventions for treatment-resistant depression in adults.
    • 8
    • PDF
    Escitalopram versus serotonin noradrenaline reuptake inhibitors as second step treatment for patients with major depressive disorder: a pooled analysis
    • 20
    • Highly Influenced
    Pharmacological treatment approaches to difficult-to-treat depression.
    • 3
    • PDF
    Aripiprazole augmentation, antidepressant combination or switching therapy in patients with major depressive disorder who are partial- or non-responsive to current antidepressants: a multi-center, naturalistic study.
    • 14

    References

    SHOWING 1-10 OF 148 REFERENCES
    Dose escalation for insufficient response to standard-dose selective serotonin reuptake inhibitors in major depressive disorder: systematic review.
    • 60
    • PDF
    Partial response, nonresponse, and relapse with selective serotonin reuptake inhibitors in major depression: a survey of current "next-step" practices.
    • 135
    Strategies for Managing Depression Refractory to Selective Serotonin Reuptake Inhibitor Treatment: A Survey of Clinicians
    • 86
    Similar effectiveness of paroxetine, fluoxetine, and sertraline in primary care: a randomized trial.
    • 295
    • PDF
    Switching to bupropion in fluoxetine-resistant major depressive disorder.
    • M. Fava, G. Papakostas, +4 authors P. Mcgrath
    • Medicine
    • Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists
    • 2003
    • 18
    Meta-analytical studies on new antidepressants.
    • 166
    • PDF
    Selective serotonin reuptake inhibitor discontinuation syndrome: a randomized clinical trial
    • 441
    • PDF
    Venlafaxine extended release versus conventional antidepressants in the remission of depressive disorders after previous antidepressant failure: ARGOS study
    • 67
    Fluoxetine treatment of patients with major depressive disorder who failed initial treatment with sertraline.
    • 186
    Combining antidepressants for treatment-resistant depression: a review.
    • 117